Search

Author/Creator Windemuth-Kieselbach, C.

2. Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer: Final results of the randomized, double-blind, placebo-controlled phase II MADONNA study. (June 2019)

Authors:
Mavratzas, A.; Baek, S.; Gerber, B.; Schmidt, M.; Moebus, V.; Foerster, F.; Grischke, E.M.; Fasching, P.; Strumberg, D.; Solomayer, E.; Klare, P.; Windemuth-Kieselbach, C.; Hartmann, S.; Schneeweiss, A.; Marmé, F.
Journal:
Breast
Issue:
Volume 45(2019)
Page Start:
22
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase II study of induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil followed by radioimmunotherapy with cetuximab and intensity-modulated radiotherapy in combination with a carbon ion boost for locally advanced tumors of the oro-, hypopharynx and larynx. (November 2018)

Authors:
Hauswald, H.; Jensen, A.D.; Krauss, J.; Haselmann, R.; Lossner, K.; Hartmann, S.; Windemuth-Kieselbach, C.; Münter, M.W.; Debus, J.
Journal:
Clinical and translational radiation oncology
Issue:
Volume 13(2018)
Page Start:
64
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Prospective evaluation of follow-up in melanoma patients in Germany – Results of a multicentre and longitudinal study. Issue 5 (March 2015)

Authors:
Livingstone, E.; Krajewski, C.; Eigentler, T.K.; Windemuth-Kieselbach, C.; Benson, S.; Elsenbruch, S.; Hauschild, A.; Rompel, R.; Meiss, F.; Mauerer, A.; Kähler, K.C.; Dippel, E.; Möllenhoff, K.; Kilian, K.; Mohr, P.; Utikal, J.; Schadendorf, D.
Journal:
European journal of cancer
Issue:
Volume 51:Issue 5(2015:Mar.)
Page Start:
653
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗